Vivos Therapeutics Stock (NASDAQ:VVOS)
Previous Close
$2.33
52W Range
$1.91 - $6.28
50D Avg
$3.32
200D Avg
$3.23
Market Cap
$13.25M
Avg Vol (3M)
$155.78K
Beta
7.28
Div Yield
-
VVOS Company Profile
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
VVOS Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
| Product/Service | Dec 24 | Dec 23 | Dec 22 |
|---|---|---|---|
| Billing Intelligence Services | $840.00K | - | - |
| Product | $7.87M | - | - |
| Service | $7.16M | - | - |
| Sponsorship Seminar Other | $1.94M | - | - |
| VIP | $2.48M | - | - |
| Appliances | $5.60M | - | - |
| Center Revenue | - | $189.00K | $561.00K |
| Management Service Revenue | - | - | $63.00K |
Fiscal year ends in Dec 24 | Currency in USD